ArticleJournal of health politics, policy and law2016
A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement.
Article in Journal of health politics, policy and law, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Deepening Accountability: The Fair Pharma Scorecard and Access to Medicines in a Fragmented Global Health Law Landscape.Health and human rights · 2025Article
- Identifying the factors influencing the development of bilateral investment treaties with health safeguards: a Machine Learning-based link prediction approach.Journal of computational social science · 2025Article
- Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.International journal of health policy and management · 2024Article
- Brexit, trade and the governance of non-communicable diseases: a research agenda.Globalization and health · 2023Review
- Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy.International journal of health policy and management · 2023Article
- Article
- Overcoming tobacco industry opposition to standardized packaging in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2022Article
- Political economy analysis of universal health coverage and health financing reforms in low- and middle-income countries: the role of stakeholder engagement in the research process.Health research policy and systems · 2021Review
- International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.Globalization and health · 2021Review
- Do international trade and investment agreements generate regulatory chill in public health policymaking? A case study of nutrition and alcohol policy in South Africa.Globalization and health · 2021Article
- Alcohol policy, multi-level governance and corporate political strategy: The campaign for Scotland's minimum unit pricing in Edinburgh, London and Brussels.British journal of politics & international relations · 2021Article
- Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review.Health policy and planning · 2021Review
- 'Tied up in a legal mess': The alcohol industry's use of litigation to oppose minimum alcohol pricing in Scotland.Scottish affairs · 2020Article
- A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.Global public health · 2019Article
- The tobacco industry's challenges to standardised packaging: A comparative analysis of issue framing in public relations campaigns in four countries.Health policy (Amsterdam, Netherlands) · 2018Review
- European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.Globalization and health · 2018Article
- Balancing science and political economy: Tobacco control and global health.Wellcome open research · 2018Article
- The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"International journal of health policy and management · 2017Article
- Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control.Globalization and health · 2017Article
- Global constitutionalism, applied to global health governance: uncovering legitimacy deficits and suggesting remedies.Globalization and health · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The importance of trade and investment agreements for health is now widely acknowledged in the literature, with much attention now focused on the impact of investor-state dispute settlement (ISDS) mechanisms. However, much of the analysis of such agreements in the health field remains largely descriptive. We theorize the implications of ISDS mechanisms for health policy by integrating the concept of global constitutionalism with veto point theory. It is argued that attempts to constitutionalize investment law, through a proliferation of International Investment Agreements (IIAs), has created a series of new veto points at which corporations may seek to block new policies aimed at protecting or enhancing public health. The multiplicity of new veto points in this global "spaghetti bowl" of IIAs creates opportunities for corporations to venue shop; that is, to exploit the agreements, and associated veto points, through which they are most likely to succeed in blocking or deterring new regulation. These concepts are illustrated with reference to two case studies of investor-state disputes involving a transnational tobacco company, but the implications of the analysis are of equal relevance for a range of other industries and health issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.